Want to see IN:MKPL full AI Analyst Report?

M K Proteins Limited (MKPL) Price & Analysis

0 Followers

MKPL Stock Chart & Stats

₹6.89

-₹0.11(-1.36%)

At close: Jan 08 4:00 PM EST

₹6.89

-₹0.11(-1.36%)

Day’s Range― - ―

52-Week Range₹3.80 - ₹8.84

Previous CloseN/A

Volume181.52K

Average Volume (3M)20.59K

Market Cap

₹1.57B

Enterprise Value₹2.51K

Total Cash (Recent Filing)₹4.38M

Total Debt (Recent Filing)₹371.38M

Price to Earnings (P/E)23.2

Beta0.95

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.18

Shares Outstanding375,372,000

10 Day Avg. Volume17,806

30 Day Avg. Volume20,591

Financial Highlights & Ratios

PEG Ratio-1.18

Price to Book (P/B)1.92

Price to Sales (P/S)0.38

P/FCF Ratio76.87

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue ReboundA 17.7% revenue rebound in FY2026 indicates renewed demand and better top-line momentum after prior declines. Sustained revenue recovery over the next several quarters would support utilization, scale benefits and provide a foundation for margin and cash-flow recovery, improving structural resilience.

Improved LeverageLeverage has meaningfully improved over recent years, reducing refinancing and liquidity strain. A lower debt-to-equity ratio increases financial flexibility, lowers interest burden risk, and provides more room to absorb shocks, supporting medium-term solvency and strategic optionality.

Equity Growth / Asset StabilityRising equity and stable asset levels strengthen the company’s capital base and improve its buffer against losses. A stronger equity position enhances creditworthiness and supports investment or working-capital needs without immediate reliance on external financing, a durable positive for operations.

Bears Say

Sharp Margin CompressionMaterial margin erosion over successive years signals structural cost pressure or pricing weakness. Persistently thin gross and net margins reduce earnings power, limit reinvestment capacity, and make the business more vulnerable to input cost spikes or competitive pressure, harming long-term profitability.

Weak And Inconsistent Cash ConversionRepeated negative operating cash flow years and modest free cash flow versus earnings indicate poor cash conversion. This reduces self-funding ability for capex, working capital, or dividends, increases reliance on external financing, and raises execution risk during downturns or cost shocks.

Choppy Revenue And Declining Net Income TrendRevenue volatility and a falling net-income trend undermine predictability of margins and cash flows. Persistent earnings variability complicates planning, budgeting and reinvestment, making sustainable margin restoration and debt servicing more challenging during adverse market or operational conditions.

M K Proteins Limited News

M K Proteins Closes Trading Window Ahead of Q1 FY2026 Results

M K Proteins Limited ( ($IN:MKPL) ) has issued an announcement. M K Proteins Limited has announced the...

2M ago

MKPL

MKPL FAQ

What was M K Proteins Limited’s price range in the past 12 months?

M K Proteins Limited lowest stock price was ₹3.80 and its highest was ₹8.84 in the past 12 months.

What is M K Proteins Limited’s market cap?

M K Proteins Limited’s market cap is ₹1.57B.

When is M K Proteins Limited’s upcoming earnings report date?

M K Proteins Limited’s upcoming earnings report date is Nov 12, 2026 which is in 88 days.

How were M K Proteins Limited’s earnings last quarter?

M K Proteins Limited released its earnings results on Aug 13, 2026. The company reported ₹0.037 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is M K Proteins Limited overvalued?

According to Wall Street analysts M K Proteins Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does M K Proteins Limited pay dividends?

M K Proteins Limited does not currently pay dividends.

What is M K Proteins Limited’s EPS estimate?

M K Proteins Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does M K Proteins Limited have?

M K Proteins Limited has 375,372,000 shares outstanding.

What happened to M K Proteins Limited’s price movement after its last earnings report?

M K Proteins Limited reported an EPS of ₹0.037 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.957%.

Which hedge fund is a major shareholder of M K Proteins Limited?

Currently, no hedge funds are holding shares in IN:MKPL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

M K Proteins Limited

M. K. Proteins Limited specializes in the production and commercial activities related to a range of refined vegetable oils and their associated derivatives. The company's diverse offerings include refined varieties such as rice bran, sunflower, cottonseed, soybean, palm, canola, and bleached rice bran oils. Furthermore, it provides by-products like rice bran fatty acid oils, rice bran waxes, gums, and spent earth. The firm also participates in the import and trade of both edible and non-edible oils. Founded in 2012, the company's operations are headquartered in Ambala, India.